KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exelixis (EXEL) Research & Development (2016 - 2026)

Historic Research & Development for Exelixis (EXEL) over the last 17 years, with Q1 2026 value amounting to $213.2 million.

  • Exelixis' Research & Development fell 1435.89% to $213.2 million in Q1 2026 from the same period last year, while for Jan 2026 it was $825.0 million, marking a year-over-year decrease of 938.12%. This contributed to the annual value of $825.0 million for FY2026, which is 938.12% down from last year.
  • According to the latest figures from Q1 2026, Exelixis' Research & Development is $213.2 million, which was down 1435.89% from $199.2 million recorded in Q4 2025.
  • Exelixis' Research & Development's 5-year high stood at $336.8 million during Q4 2022, with a 5-year trough of $156.7 million in Q2 2022.
  • For the 5-year period, Exelixis' Research & Development averaged around $229.5 million, with its median value being $217.9 million (2024).
  • As far as peak fluctuations go, Exelixis' Research & Development skyrocketed by 6726.51% in 2023, and later crashed by 3307.88% in 2024.
  • Over the past 5 years, Exelixis' Research & Development (Quarter) stood at $336.8 million in 2022, then decreased by 27.36% to $244.7 million in 2023, then dropped by 9.03% to $222.6 million in 2024, then fell by 10.52% to $199.2 million in 2025, then rose by 7.07% to $213.2 million in 2026.
  • Its Research & Development stands at $213.2 million for Q1 2026, versus $199.2 million for Q4 2025 and $200.4 million for Q3 2025.